{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:15:22Z","timestamp":1768774522408,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00104-022-01696-7","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T17:03:10Z","timestamp":1663002190000},"page":"1152-1157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aktuelle Behandlungsempfehlungen beim Pseudomyxoma peritonei","Current treatment recommendations for pseudomyxoma peritonei"],"prefix":"10.1007","volume":"93","author":[{"given":"H.","family":"Leebmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Piso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1245\/s10434-021-10093-z","volume":"28","author":"N Ahmadi","year":"2021","unstructured":"Ahmadi\u00a0N, Kostadinov\u00a0D, Sakata\u00a0S et\u00a0al (2021) Managing recurrent pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: a dilemma for patients and surgeons. Ann Surg Oncol 28:7809\u20137820","journal-title":"Ann Surg Oncol"},{"key":"1696_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","volume":"42","author":"N Ansari","year":"2016","unstructured":"Ansari\u00a0N, Chandrakumaran\u00a0K, Dayal\u00a0S et\u00a0al (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000\u00a0patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol 42:1035\u20131041","journal-title":"Eur J Surg Oncol"},{"key":"1696_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/cncr.29744","volume":"122","author":"EA Asare","year":"2016","unstructured":"Asare\u00a0EA, Compton\u00a0CC, Hanna\u00a0NN et\u00a0al (2016) The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base. Cancer 122:213\u2013221","journal-title":"Cancer"},{"key":"1696_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.suronc.2019.03.004","volume":"29","author":"L Benhaim","year":"2019","unstructured":"Benhaim\u00a0L, Faron\u00a0M, Gelli\u00a0M et\u00a0al (2019) Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei. Surg Oncol 29:78\u201383","journal-title":"Surg Oncol"},{"key":"1696_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr\u00a0NJ, Cecil\u00a0TD, Mohamed\u00a0F et\u00a0al (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol 40:14\u201326","journal-title":"Am J Surg Pathol"},{"key":"1696_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1245\/s10434-017-6214-7","volume":"25","author":"HA Choudry","year":"2018","unstructured":"Choudry\u00a0HA, Pai\u00a0RK, Shuai\u00a0Y et\u00a0al (2018) Impact of cellularity on oncologic outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for pseudomyxoma peritonei. Ann Surg Oncol 25:76\u201382","journal-title":"Ann Surg Oncol"},{"key":"1696_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/SLA.0b013e31820b4dba","volume":"253","author":"TC Chua","year":"2011","unstructured":"Chua\u00a0TC, Liauw\u00a0W, Zhao\u00a0J et\u00a0al (2011) Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Ann Surg 253:769\u2013773","journal-title":"Ann Surg"},{"key":"1696_CR8","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua\u00a0TC, Moran\u00a0BJ, Sugarbaker\u00a0PH et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a\u00a0strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J\u00a0Clin Oncol 30:2449\u20132456","journal-title":"J Clin Oncol"},{"key":"1696_CR9","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","volume":"27","author":"JM Davison","year":"2014","unstructured":"Davison\u00a0JM, Choudry\u00a0HA, Pingpank\u00a0JF et al (2014) Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a\u00a0three-tiered assessment of tumor grade. Mod Pathol 27:1521\u20131539","journal-title":"Mod Pathol"},{"key":"1696_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/bjs.10716","volume":"105","author":"JB Delhorme","year":"2018","unstructured":"Delhorme\u00a0JB, Severac\u00a0F, Averous\u00a0G et al (2018) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg 105:668\u2013676","journal-title":"Br J Surg"},{"key":"1696_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/000313481207800234","volume":"78","author":"JM Foster","year":"2012","unstructured":"Foster\u00a0JM, Gupta\u00a0PK, Carreau\u00a0JH et\u00a0al (2012) Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei. Am Surg 78:171\u2013177","journal-title":"Am Surg"},{"key":"1696_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12957-016-0996-0","volume":"14","author":"JM Foster","year":"2016","unstructured":"Foster\u00a0JM, Sleightholm\u00a0RL, Wahlmeier\u00a0S et al (2016) Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a\u00a0new approach to surveillance for peritoneal metastasis. World J Surg Oncol 14:243","journal-title":"World J Surg Oncol"},{"key":"1696_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1245\/s10434-016-5588-2","volume":"24","author":"K Fournier","year":"2017","unstructured":"Fournier\u00a0K, Rafeeq\u00a0S, Taggart\u00a0M et al (2017) Low-grade appendiceal mucinous neoplasm of uncertain malignant potential (LAMN-UMP): prognostic factors and implications for treatment and follow-up. Ann Surg Oncol 24:187\u2013193","journal-title":"Ann Surg Oncol"},{"key":"1696_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/1457496915598759","volume":"105","author":"JA Funder","year":"2016","unstructured":"Funder\u00a0JA, Jepsen\u00a0KV, Stribolt\u00a0K et\u00a0al (2016) Palliative surgery for pseudomyxoma peritonei. Scand J Surg 105:84\u201389","journal-title":"Scand J Surg"},{"key":"1696_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.ejso.2018.06.023","volume":"44","author":"K Govaerts","year":"2018","unstructured":"Govaerts\u00a0K, Chandrakumaran\u00a0K, Carr\u00a0NJ et al (2018) Single centre guidelines for radiological follow-up based on 775\u00a0patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei. Eur J Surg Oncol 44:1371\u20131377","journal-title":"Eur J Surg Oncol"},{"key":"1696_CR16","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1245\/s10434-017-5938-8","volume":"24","author":"TE Grotz","year":"2017","unstructured":"Grotz\u00a0TE, Overman\u00a0MJ, Eng\u00a0C et\u00a0al (2017) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for moderately and poorly differentiated appendiceal adenocarcinoma: survival outcomes and patient selection. Ann Surg Oncol 24:2646\u20132654","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1696_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1245\/s10434-017-6305-5","volume":"25","author":"M Guaglio","year":"2017","unstructured":"Guaglio\u00a0M, Sinukumar\u00a0S, Kusamura\u00a0S et al (2017) Clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol 25(4):878\u2013884","journal-title":"Ann Surg Oncol"},{"key":"1696_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10147-022-02147-3","volume":"27","author":"T Kitai","year":"2022","unstructured":"Kitai\u00a0T, Yonemura\u00a0Y (2022) Recurrence of initially localized appendiceal mucinous neoplasms after radical resection: survey analysis and literature review. Int J Clin Oncol 27:1043\u20131050","journal-title":"Int J Clin Oncol"},{"key":"1696_CR19","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1002\/cam4.3009","volume":"9","author":"BC Kolla","year":"2020","unstructured":"Kolla\u00a0BC, Petersen\u00a0A, Chengappa\u00a0M et\u00a0al (2020) Impact of adjuvant chemotherapy on outcomes in appendiceal cancer. Cancer Med 9:3400\u20133406","journal-title":"Cancer Med"},{"key":"1696_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-021-01723-6","volume":"16","author":"YL Lin","year":"2021","unstructured":"Lin\u00a0YL, Xu\u00a0DZ, Li\u00a0XB et\u00a0al (2021) Consensuses and controversies on pseudomyxoma peritonei: a\u00a0review of the published consensus statements and guidelines. Orphanet J Rare Dis 16:85","journal-title":"Orphanet J Rare Dis"},{"key":"1696_CR21","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1245\/s10434-021-11153-0","volume":"29","author":"CW Mangieri","year":"2022","unstructured":"Mangieri\u00a0CW, Moaven\u00a0O, Valenzuela\u00a0CD et al (2022) Utility of neoadjuvant chemotherapy for peritoneal carcinomatosis secondary to high-grade appendiceal neoplasms for patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 29:2641\u20132648","journal-title":"Ann Surg Oncol"},{"key":"1696_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2021-207883","author":"L Martin-Roman","year":"2021","unstructured":"Martin-Roman\u00a0L, Lozano\u00a0P, Gomez\u00a0Y et al (2021) Which classification system defines best prognosis of mucinous neoplasms of the appendix with peritoneal dissemination: TNM vs PSOGI? J\u00a0Clin Pathol. https:\/\/doi.org\/10.1136\/jclinpath-2021-207883","journal-title":"J Clin Pathol"},{"key":"1696_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/bjs.8739","volume":"99","author":"JR McDonald","year":"2012","unstructured":"McDonald\u00a0JR, O\u2019Dwyer\u00a0ST, Rout\u00a0S et al (2012) Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms. Br J Surg 99:987\u2013992","journal-title":"Br J Surg"},{"key":"1696_CR24","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1245\/s10434-021-10994-z","volume":"29","author":"AA Memon","year":"2022","unstructured":"Memon\u00a0AA, Godbole\u00a0C, Cecil\u00a0T et\u00a0al (2022) Overall survival is more closely associated with peritoneal than primary appendiceal pathological grade in pseudomyxoma peritonei with discordant pathology. Ann Surg Oncol 29:2607\u20132613","journal-title":"Ann Surg Oncol"},{"key":"1696_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/bjs5.97","volume":"3","author":"F Mercier","year":"2019","unstructured":"Mercier\u00a0F, Dagbert\u00a0F, Pocard\u00a0M et\u00a0al (2019) Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open 3:195\u2013202","journal-title":"BJS Open"},{"issue":"4","key":"1696_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11605-019-04239-4","volume":"24","author":"V Narasimhan","year":"2020","unstructured":"Narasimhan\u00a0V, Wilson\u00a0K, Britto\u00a0M et al (2020) Outcomes following cytoreduction and HIPEC for pseudomyxoma peritonei: 10-year experience. J\u00a0Gastrointest Surg 24(4):899\u2013906","journal-title":"J Gastrointest Surg"},{"key":"1696_CR27","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1245\/s10434-020-08535-1","volume":"27","author":"A Nikiforchin","year":"2020","unstructured":"Nikiforchin\u00a0A, King\u00a0MC, Baron\u00a0E et al (2020) Impact of mucin cellularity and distribution on survival in newly diagnosed patients with low-grade appendiceal mucinous neoplasm treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 27:4908\u20134917","journal-title":"Ann Surg Oncol"},{"key":"1696_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1245\/s10434-020-08655-8","volume":"28","author":"T Patrick-Brown","year":"2021","unstructured":"Patrick-Brown\u00a0T, Carr\u00a0NJ, Swanson\u00a0DM et al (2021) Estimating the prevalence of pseudomyxoma peritonei in Europe using a\u00a0novel statistical method. Ann Surg Oncol 28:252\u2013257","journal-title":"Ann Surg Oncol"},{"key":"1696_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13193-016-0516-2","volume":"7","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy\u00a0V (2016) Pathology of mucinous appendiceal tumors and pseudomyxoma peritonei. Indian J Surg Oncol 7:258\u2013267","journal-title":"Indian J Surg Oncol"},{"key":"1696_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/02656736.2020.1772511","volume":"37","author":"O Sgarbura","year":"2020","unstructured":"Sgarbura\u00a0O, Al Hosni\u00a0M, Petruzziello\u00a0A et al (2020) Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept. Int J Hyperthermia 37:585\u2013591","journal-title":"Int J Hyperthermia"},{"key":"1696_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","volume":"245","author":"RM Smeenk","year":"2007","unstructured":"Smeenk\u00a0RM, Verwaal\u00a0VJ, Antonini\u00a0N et\u00a0al (2007) Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245:104\u2013109","journal-title":"Ann Surg"},{"key":"1696_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker\u00a0PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7:69\u201376","journal-title":"Lancet Oncol"},{"key":"1696_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12957-021-02171-z","volume":"19","author":"B Trilling","year":"2021","unstructured":"Trilling\u00a0B, Brind\u2019Amour\u00a0A, Hamad\u00a0R et al (2021) Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index. World J Surg Oncol 19:60","journal-title":"World J Surg Oncol"},{"key":"1696_CR34","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1245\/s10434-012-2789-1","volume":"20","author":"KM Turner","year":"2013","unstructured":"Turner\u00a0KM, Hanna\u00a0NN, Zhu\u00a0Y et al (2013) Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer. Ann Surg Oncol 20:1068\u20131073","journal-title":"Ann Surg Oncol"},{"key":"1696_CR35","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1245\/s10434-022-11440-4","volume":"29","author":"CD Valenzuela","year":"2022","unstructured":"Valenzuela\u00a0CD, Mangieri\u00a0CW, Garland-Kledzik\u00a0M et al (2022) Timing of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for recurrent low-grade appendiceal mucinous neoplasms. Ann Surg Oncol 29:3422\u20133431","journal-title":"Ann Surg Oncol"},{"key":"1696_CR36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1245\/s10434-017-6315-3","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos\u00a0KI, Bartlett\u00a0D, Moran\u00a0B et al (2018) PCI is not predictive of survival after complete CRS\/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol 25:674\u2013678","journal-title":"Ann Surg Oncol"},{"key":"1696_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/PAS.0b013e31817ec31e","volume":"33","author":"RK Yantiss","year":"2009","unstructured":"Yantiss\u00a0RK, Shia\u00a0J, Klimstra\u00a0DS et al (2009) Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol 33:248\u2013255","journal-title":"Am J Surg Pathol"},{"key":"1696_CR38","doi-asserted-by":"publisher","first-page":"554910","DOI":"10.3389\/fsurg.2020.554910","volume":"7","author":"S Zhou","year":"2020","unstructured":"Zhou\u00a0S, Zhao\u00a0H, He\u00a0X (2020) The prognostic impact of pathology on patients with pseudomyxoma peritonei undergoing debulking surgery: a systematic review and meta-analysis of retrospective studies. Front Surg 7:554910","journal-title":"Front Surg"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-022-01696-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-022-01696-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-022-01696-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T19:11:32Z","timestamp":1669835492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-022-01696-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s00104-022-01696-7","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"value":"2731-6971","type":"print"},{"value":"2731-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"18 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Leebmann und P.\u00a0Piso geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}